ES8605812A1 - Procedimiento para obtener un preparado de factor xiii - Google Patents

Procedimiento para obtener un preparado de factor xiii

Info

Publication number
ES8605812A1
ES8605812A1 ES543422A ES543422A ES8605812A1 ES 8605812 A1 ES8605812 A1 ES 8605812A1 ES 543422 A ES543422 A ES 543422A ES 543422 A ES543422 A ES 543422A ES 8605812 A1 ES8605812 A1 ES 8605812A1
Authority
ES
Spain
Prior art keywords
factor xiii
obtaining
procedure
xiii preparation
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES543422A
Other languages
English (en)
Spanish (es)
Other versions
ES543422A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Behringwerke AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke AG filed Critical Behringwerke AG
Publication of ES543422A0 publication Critical patent/ES543422A0/es
Publication of ES8605812A1 publication Critical patent/ES8605812A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1025—Acyltransferases (2.3)
    • C12N9/104—Aminoacyltransferases (2.3.2)
    • C12N9/1044—Protein-glutamine gamma-glutamyltransferase (2.3.2.13), i.e. transglutaminase or factor XIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/85—Reproductive organs or embryos
    • Y10S530/851—Placenta; amniotic fluid

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ES543422A 1984-05-25 1985-05-23 Procedimiento para obtener un preparado de factor xiii Expired ES8605812A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843419581 DE3419581A1 (de) 1984-05-25 1984-05-25 Verfahren zur gewinnung einer faktor xiii-praeparation sowie ihre verwendung

Publications (2)

Publication Number Publication Date
ES543422A0 ES543422A0 (es) 1986-01-16
ES8605812A1 true ES8605812A1 (es) 1986-01-16

Family

ID=6236872

Family Applications (1)

Application Number Title Priority Date Filing Date
ES543422A Expired ES8605812A1 (es) 1984-05-25 1985-05-23 Procedimiento para obtener un preparado de factor xiii

Country Status (8)

Country Link
US (1) US4597899A (en:Method)
EP (1) EP0162426A3 (en:Method)
JP (1) JPS60258123A (en:Method)
DE (1) DE3419581A1 (en:Method)
DK (1) DK231885A (en:Method)
ES (1) ES8605812A1 (en:Method)
FI (1) FI852065L (en:Method)
GR (1) GR851270B (en:Method)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3621371A1 (de) * 1986-03-12 1987-09-17 Behringwerke Ag Gentechnische herstellung von faktor xiiia
US6869790B1 (en) 1986-03-12 2005-03-22 Aventis Behring Gmbh Preparation of DNA encoding factor XIIIA
US6746866B1 (en) 1986-03-12 2004-06-08 Aventis Behring Gmbh Preparation of factor XIIIa by gene manipulation
FR2600078B1 (fr) * 1986-06-12 1989-07-13 Merieux Inst Procede de preparation de facteur xiii a partir du placenta
DE3734923C1 (de) * 1987-10-15 1989-01-26 Biotest Pharma Gmbh Verfahren zur Herstellung einer sterilen Plasmaproteinloesung,die Fibrinogen und den Gerinnungsfaktor XIII enthaelt
US5204447A (en) * 1988-11-14 1993-04-20 Zymogenetics, Inc. Purification of factor xiii
US5612456A (en) * 1988-11-14 1997-03-18 Zymogenetics, Inc. Factor XIII compositions
JPH03240738A (ja) * 1990-02-20 1991-10-28 Hoechst Japan Ltd 糖尿病性壊疽治療剤
DE69328228T2 (de) * 1992-04-21 2000-12-21 Ajinomoto Co., Inc. Wundheilmittel
EP1784415A2 (en) * 2004-08-27 2007-05-16 Novo Nordisk Health Care AG Purification of factor xiii polypeptides from biological materials
ES2378777T3 (es) * 2004-11-23 2012-04-17 Zymogenetics, Inc. Purificación del factor XIII humano recombinante
WO2010131249A2 (en) 2009-05-12 2010-11-18 Hadasit Medical Research Services And Development Ltd. Prosthetic devices coated with heated cross-linked fibrin
CN107375334B (zh) * 2017-08-02 2020-08-18 广州准优生物科技有限公司 胎盘提取物及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3310471A (en) * 1965-05-13 1967-03-21 Upjohn Co Placental lactogenic factor process
US3409605A (en) * 1965-06-15 1968-11-05 American Cyanamid Co Concentration and purification of growth factor-placental origin (human)
US3931399A (en) * 1970-12-22 1976-01-06 Behringwerke Aktiengesellschaft Process for isolating a fibrin-stabilizing factor
US3904751A (en) * 1970-12-22 1975-09-09 Behringwerke Ag Process for isolating a fibrin stabilizing factor from human placenta
JPS6029687B2 (ja) * 1978-11-07 1985-07-12 株式会社ミドリ十字 ヒト胎盤由来血液凝固第１０３因子の濃縮液の製造方法
JPS56135418A (en) * 1980-03-27 1981-10-22 Green Cross Corp:The Heat treatment of aqueous solution containing 8 factor of coagulation of blood derived from human

Also Published As

Publication number Publication date
DK231885D0 (da) 1985-05-23
EP0162426A2 (de) 1985-11-27
JPS60258123A (ja) 1985-12-20
GR851270B (en:Method) 1985-11-25
ES543422A0 (es) 1986-01-16
DK231885A (da) 1985-11-26
FI852065A7 (fi) 1985-11-26
DE3419581A1 (de) 1985-11-28
US4597899A (en) 1986-07-01
FI852065L (fi) 1985-11-26
EP0162426A3 (de) 1987-05-20
FI852065A0 (fi) 1985-05-23

Similar Documents

Publication Publication Date Title
DE3064888D1 (en) Aqueous solutions of proteins stable against denaturization, process for their manufacture, and their utilization
DE3572179D1 (en) Blood coagulation inhibiting proteins, process for preparing them and their use
ES8605812A1 (es) Procedimiento para obtener un preparado de factor xiii
NO880022L (no) Fremstilling av m-csf.
IL59621A0 (en) Compositions,method and apparatus for the determination of blood gases and blood ph
SE7707992L (sv) Forfarande for framstellning av en blodkoagulationsbefremjande preparation av humanblodplasma
NO830110L (no) 6-substituert-s-triazolo(3,4-a)ftalazinderivater og fremgangsmaate for deres fremstilling
EP0013983A3 (en) Antineoplastics on the basis of little or non-irritating diterpenalcohols,and derivatives thereof, and their preparation
EP0053338A3 (en) Process for the preparation of blood coagulation factors, and preparation containing factors ix and x
ES482097A1 (es) Procedimiento para preparar derivados acilicos de carnitina.
JPS57163391A (en) Platinum diamine complex, manufacture and use for treatment of cancer
PH23978A (en) Process for the preparation of glycerophosphocholine and glycerophosphoethanolamine derivatives
GB2100601B (en) An aromatase-inhibitor for use in a method of prophylaxis and/or of treatment by therapy of prostatic hyperplasia, and pharmaceutical preparations suitable for such a use.
DE3063883D1 (en) Process for preparing a collagen solution, such a solution and its use
EP0024182A3 (en) Thermo-stable micro-organism and proteolytic enzyme prepared therefrom, and processes for the preparation of the micro-organism and the proteolytic enzyme
PT86298A (en) Method for the treatment of an aqueous medium with copolymers containing acrylamidoalkane sulfonic acid
DE3067620D1 (en) Process for the preparation of acicular ferrimagnetic iron oxide, and its application
IL52899A0 (en) Tissue specific protein and process for preparing same
AU527089B2 (en) Absorbant facing for medical purposes and process for making same
DE3061672D1 (en) Amino derivatives of benzothiazole, process for their preparation and their use in therapy
IE40267L (en) Alkanolamine derivatives
NL174345B (nl) Zuur alkalicitraat, werkwijze ter bereiding daarvan en therapeutisch preparaat.
ES8102108A1 (es) Procedimiento para preparar una composicion antitumoral que contiene como ingrediente activo una sal del acido tiazoli- din-4-carboxilico.
HUT36783A (en) Process for preparing 1,7-diphenyl-3-methyl-aza-7-cyano-8-methyl-nonane
DE3067643D1 (en) Protein pp 11, process for its isolation and its use